
Last updated: 2026-09-16 10:32:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
GlucoTrack, Inc. (GCTK) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.35, with a market capitalisation of $1.96M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.22 to $136.29. This page covers its latest market performance, valuation, price trends and company information.
$1.96M | |
$2.33 | |
$381,600.00 | |
$2.22 | |
$2.27 | |
1.72K | |
758.33K | |
-- | |
$136.29 | |
$2.22 | |
-- | |
-- |
GlucoTrack, Inc. (GCTK) is trading at $2.35 in pre-market trading as of 2026-09-16 10:26:00, up 3.52% ($0.08) from the previous close of $2.27
Pre-market trading shows how investors are pricing GCTK before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, GlucoTrack, Inc. (GCTK) moved from $2.98 to $2.35, representing a decline of 21.14% ($0.63).
The stock traded between $2.22 and $3.31 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 163.28 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.1%
GCTK is currently trading at $2.35, placing it 0.1% of the way from its 52-week low of $2.22 to its 52-week high of $136.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 15 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GlucoTrack, Inc. (GCTK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.